A Study of the Safety and Tolerability of MEDI-551 in Scleroderma.
The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-551 over escalating single doses in adult subjects with Scleroderma. Identifier NCT00946699. Clinicaltrials.gov. This study is currently recruiting participants. (Also see: Clinical Trials)
These items were posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
No replies to this topic